SAM
DGX icon

Sabadell Asset Management’s Quest Diagnostics DGX Stock Holding History

Sabadell Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,366
Closed -$602K – 154
2022
Q1 		$602K Buy
4,366
+462
+12% +$64.4K 0.1% 141
2021
Q4 		$566K Buy
3,904
+327
+9% +$49.8K 0.09% 136
2021
Q3 		$520K Buy
3,577
+448
+14% +$65.5K 0.09% 141
2021
Q2 		$413K Buy
+3,129
New +$410K 0.07% 144

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Sabadell Asset Management's DGX Position: Q2 2022 in Review

Sabadell Asset Management sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 4,366 shares — an estimated $602K sold.

Sabadell Asset Management first reported a position in DGX in Q2 2021 and held it in 4 quarters. The position peaked at $602K in Q1 2022. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Sabadell Asset Management reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Sabadell Asset Management sold 4,366 Quest Diagnostics shares in Q2 2022, an estimated $602K.
  • Sabadell Asset Management first reported a position in Quest Diagnostics in Q2 2021 and held it in 4 quarters.
  • Sabadell Asset Management's Quest Diagnostics position peaked at $602K in Q1 2022.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Sabadell Asset Management's 13F filing for Q2 2022, filed 23 Jan 2024.